BackStealth BioTherapeutics Overview

Stealth BioTherapeutics Long Term Debt

Track Stealth BioTherapeutics's long-term debt ($14M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$13.78M

Peer average

Loading

Stealth BioTherapeutics Long Term Debt History

Loading

Stealth BioTherapeutics vs. peers: Long Term Debt Comparison

Loading

Stealth BioTherapeutics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Stealth BioTherapeutics (MITO) FAQ

Stealth BioTherapeutics (MITO) currently reports a long-term debt of $14M as of March 2022. In the prior-year period, the figure was $0. Use the charts on this page to explore Stealth BioTherapeutics's long-term debt history and peer comparisons.

Stealth BioTherapeutics's long-term debt changed from $0 to $14M (period ending March 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Stealth BioTherapeutics reported $14M in long-term debt as of March 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $14M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Stealth BioTherapeutics, and consider following MITO for alerts when major investors trade the stock.

Stealth BioTherapeutics is classified in the Healthcare sector. On long-term debt, it currently shows $14M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MITO with unrelated industries.